breakingnews

Loss of smell in COVID-19 patients: MRI data reveals a transient edema of the olfactory clefts

Stroke risk, phenotypes, and death in COVID-19: Systematic review and newly reported cases

Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome studies in 8 stuporous and comatose patients

Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong

Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection

Humoral Immune Response to SARS-CoV-2 in Iceland

Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'

In this paper, recently published in Stroke, the authors aimed to compare anterior circulation large vessel occlusion stroke severity between patients with and without COVID-19.

In this paper, recently published in Neurocritical Care, the authors conducted a retrospective cohort study of patients with haemorrhagic stroke (both non-traumatic intracerebral haemorrhage and spontaneous non-aneurysmal subarachnoid haemorrhage) who were hospitalised between March 1, 2020, and May 15, 2020, within a major healthcare system in New York, during the coronavirus pandemic.

In this paper, recently published in Arteriosclerosis, Thrombosis, and Vascular Biology, the authors aimed to determine the prevalence of D-dimer elevation in COVID-19 hospitalisation, trajectory of D-dimer levels during hospitalisation, and association with clinical outcomes.

In this longitudinal study, recently published in the European Journal of Neurology, the authors sought to describe the neurological manifestations of patients with COVID‐19 and gain pathophysiological insights especially with respect to the cytokine release syndrome (CRS).

In this paper, recently published in the European Journal of Neurology, the authors reported four cases of COVID‐19‐related encephalopathy. The diagnosis was made in patients with confirmed COVID‐19 who presented with new‐onset cognitive disturbances, central focal neurological signs or seizures.